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Abstract 
Background: Hyperglycemia-induced inflammation causes the dysfunction of blood vessels, and Toll-like receptor 
4 (TLR4) plays a key role in inflammation-induced angiogenesis. However, the impact of TLR4 on the pathogenesis of 
diabetic retinopathy (DR) is poorly understood. In this study, we examined the expression of TLR4 in retinal vascular 
endothelial cells of patients with DR and diabetic mice, and explored the role of TLR4 in mediating inflammatory 
responses by human microvascular endothelial cells (HMEC-1) under high-glucose condition.
Methods: The expression of TLR4 in retinal vascular endothelial cells of patients with proliferative diabetic retin-
opathy and diabetic mice induced by streptozotocin was examined using immunofluorescence. HMEC-1 cells were 
cultured and the expression of TLR4, MyD88 and Interleukin-1β (IL-1β) was examined under high-glucose condition. 
Endothelial cells with TLR4 silencing and antagonist of TLR4 as well as endothelial cells from TLR4 deficient mice were 
used to study the effect of activated TLR4 on inflammation induced by high-glucose treatment.
Results: We observed that TLR4 was detected in CD31-labled human retinal vascular endothelia and its expression 
was markedly increased in fibrovascular membranes from DR patients and in retinal vascular endothelial cells of 
diabetic mice. The expression of TLR4, MyD88 and IL-1β was enhanced by high glucose in cultured HMEC-1 and the 
expression of TLR4 and IL-1β was inhibited by TLR4 siRNA knock-down and TLR4 antagonist. The expression of IL-1β by 
endothelial cells from TLR4 deficient mice under high glucose condition was decreased.
Conclusions: Our results revealed that hyperglycemia induced overexpression and activation of TLR4 in endothelial 
cells. This effect may lead to inflammatory responses contribute to the pathogenesis of diabetic retinopathy.
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Background
Diabetic retinopathy (DR) is a common microvascular 
complication of diabetes. It remains the major cause of 
blindness in developed countries. Multifactors have been 
shown to contribute to the initiation and progression 
of the disease in which inflammation is pivotal. Inflam-
mation confers an increased risk for microvascular and 
macrovascular complications of diabetes. The proinflam-
matory phenotype in DR is characterized by elevated 
retinal cytokines, chemokines and adhesion molecules [1, 
2].
Endothelial cells are key participants in retinal ischemic 
vasculopathies and their dysfunction is the initial event 
of microvascular disorder in DR [3]. Chronic inflamma-
tory responses in retinal endothelia cause the production 
of inflammatory mediators, leading to increased vascu-
lar permeability, apoptosis of endothelial cells and neo-
vascularization [3]. Hyperglycemia, one of the major risk 
factors for DR, could trigger inflammation and leads to 
vascular complications. Upon exposure to high glucose, 
endothelial cells show a series of inflammatory responses, 
such as reduced NO production [4], but enhanced 
NF-κB activation [5], inflammatory gene expression [6] 
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and leukocyte recruitment [7] by upregulated produc-
tion of chemoattractants [8]. However, how hyperglyce-
mia induces inflammation to contribute to DR remains 
unknown.
Toll-like receptors (TLRs) are pattern recognition 
receptors and recognize conserved pathogen-associated 
molecular patterns (PAMPs) and non-microbe molecules 
including endogenous ligands released during tissue 
damage and inflammation [9]. TLR activation triggers 
a signaling cascade leading to cytokine production and 
initiation of an adaptive immune response. TLR expres-
sion is increased in a plethora of inflammatory disorders, 
including diabetes [10]. Among TLRs, TLR4 recognizes 
lipopolysaccharide (LPS) from Gram-negative bacte-
ria and endogenous ligands such as high-mobility group 
box 1 (HMGB1) and is expressed in multiple cells, such 
as endothelial cells and monocytes [11]. In retina, it has 
been reported that TLR4 was expressed in the diverse 
retinal cells, including retinal pigment epithelium, pho-
toreceptors, astrocytes, microglia and retinal vascular 
endothelial cells [12].
TLR4 activates both the myeloid differentiation fac-
tor 88 (MyD88)-dependent pathway, which induces 
inflammatory cytokines, and TRIF-dependent pathway 
responsible for the induction of type I interferon. Sev-
eral studies have shown that the expression of TLR4 
is increased in atherosclerotic plaques of animal mod-
els of atherosclerosis. The lesion size, lipid content, and 
macrophage infiltration in atherosclerotic plaque were 
reduced in TLR4 knockout mice [13]. TLR4-mediated 
pathway also promotes dysfunction of mesangial cells 
that resulted in occluding of glomerular capillaries in 
Diabetic nephropathy [14]. Recent results suggest an 
association between Asp299Gly polymorphism in TLR4 
gene and early onset of DR in DM2 patients. Toll-like 
receptor 4 polymorphisms was associated with a higher 
prevalence of retinopathy [15, 16]. Hyperglycemia and 
free fatty acids (FFAs) synergistically promoted oxida-
tive stress to aggravated the dysfunction of endothelia 
and insulin resistance, which are mediated by activated 
TLR4 [17, 18]. Additionally, the expression of down-
stream factors of TLR4 including MyD88 and NF-κB, was 
significantly increased in cells exposed to high glucose 
[17, 19]. This may lead to the secretion of inflammatory 
cytokines including IL-1β [20]. Studies showed that the 
level of IL-1β was significantly elevated in vitreous fluid 
of patients with proliferative diabetic retinopathy and in 
the retina fluid of DR rats [21]. Enhanced expression of 
TLR4 has been shown in monocytes of diabetic patients 
with microvascular complications [22]. Furthermore, the 
studies showed the involvement of TLR4 in other human 
diabetic complications like nephropathy, wound healing 
impairment. Lin et al. reported that Toll-like receptor 4 
promoted tubular inflammation in diabetic nephropathy 
[23]. Down-regulation of TLR4 was shown in the impair-
ment of wound healing in T2DM patients [24, 25]. TLR4 
played an important role in the initiation and progres-
sion of cardiovascular pathologies [26]. Our previous 
study showed that TLR4 plays a critical role in inflam-
mation-induced angiogenesis by promoting endothelial 
cell sprouting, proliferation and chemotaxis in a mouse 
model of alkali-induced corneal neovascularization [27]. 
We also found that TLR4 deficiency could protect mice 
from angiogenesis in oxygen-induced retinopathy model 
[28, 29].
Accumulating evidence implicated that TLR4-medi-
ated inflammation was involved in diabetic vascular 
complication. However, the role of TLR4 in mediating 
the pathogenesis of DR by endothelial cells remains to be 
elucidated. In this study, we examined the role of TLR4-
dependent pathway in high glucose-induced inflamma-
tory responses in retinal vascular endothelial cells. We 
demonstrate that high glucose challenge enhances the 
expression of TLR4 and the secretion of inflammatory 
factors by human endothelial cells. These results suggest 
an important role of hyperglycemia-induced expression 
and activation of TLR4 in diabetic retinopathy.
Methods
Patients and tissue samples
Five patients diagnosed as PDR were recruited from 
Zhongshan Ophthalmic Centre, Sun Yat-sen University, 
Guangzhou, China. Five normal human eye balls were 
from the Eye Bank of Zhongshan Ophthalmic Centre 
(Table  1). PDR patients underwent a series of ophthal-
mic examination, including the history of previous ocu-
lar treatments, slit-lamp biomicroscopy, gonioscopy 
ophthalmoscopy, fluorescein angiography, and fundus 
color photography. The severity of diabetic retinopathy 
was assessed based on the standardized fundus color 
photographs and on the fluorescein angiograms. The 
medical examination included fasting plasma concentra-
tions of blood glucose and glycosylated hemoglobin. All 
patients received vitrectomy because of vitreous hem-
orrhage. Fibrovascular membranes from PDR patients 
were obtained during the surgery. The size are about 
2.0 mm × 2.0 mm × 0.5 mm. After immersed in PBS for 
10 s three times, the tissues were embedded in OCT for 
section. This research was carried out in accordance with 
the principles of the Declaration of Helsinki as revised 
in 2000. Institutional Ethics Committee approval and 
informed consent from all patients were obtained.
Animal studies
C57BL/6 mice were purchased from Experimental Ani-
mal Centre of Sun Yat-sen University of Medical Science 
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(Guangzhou, China). Care, use and the treatment of all 
animals were in strict agreement with the guidelines of 
the Association for Research in Vision and Ophthalmol-
ogy Statement for the Use of Animals in Ophthalmic and 
Visual Research and approved by the institutional animal 
care and use committees in Zhongshan ophthalmic cen-
tre. To induce diabetes, 6-week-old C57BL/6 mice were 
given five consecutive intraperitoneal injections of strep-
tozotocin (STZ; 60 mg/kg body wt/day) (Sigma-Aldrich) 
or vehicle as control. Six and eight weeks after injection, 
mice were humanely killed and eyes were embedded in 
OCT for section.
Immunofluorescence
Dual-color immunofluorescence staining was performed 
on frozen sections of the fibrovascular membranes and 
mouse eye balls with a mouse anti-human or anti-mouse 
TLR4 monoclonal antibody (1:100 dilution; Santa Cruz 
Biotechnology, California, USA; 1:100 dilution; Abcam, 
Cambridge, MA, USA) and with rabbit anti-human/
mouse CD31 polyclonal IgG (1:100 dilution; Biosynthe-
sis Biotechnology Co, Ltd, Beijing, China). The samples 
were then incubated with secondary goat anti-rabbit 
IgG antibody Alexa Fluor 555 and a goat anti-mouse IgG 
antibody Alexa Fluor 488 (1:500 dilution, Cell Signal-
ing Technology, Boston, MA, USA) for 1  h at 37  °C in 
the dark, followed by a 5-min incubation with Hoechst 
33258 (1:1000 dilution; Sigma-Aldrich, St. Louis, Mis-
souri, USA). Human retinal sections were examined at 
400× with fluorescence microscope (Axioskop; Carl 
Zeiss, Thornwood, NY, USA) and mouse retinal sections 
were examined at 400× by laser confocal microscope 
(LSCM 510 META; Oberkochen, Germany), maintaining 
identical settings. We further measured TLR4-immuno-
fluorescence relative intensity in each optical slice along 
lines around inner layer of blood vessels in human retina 
samples and transecting inner layer of mouse retina by 
Image-Pro Plus 6.0 (Media Cybernetics, Silver Spring, 
Maryland, USA). Image processing was performed with 
Adobe Photoshop CS 3.0 (Adobe Systems, San Jose, CA, 
USA).
Cell culture
HMEC-1 human microvascular endothelial cell line 
was obtained from American Type Culture Collection 
(Manassas, VA, USA). HMEC-1 cells were cultured in 
human endothelial-SFM (5.5  mmol/L glucose, Invit-
rogen, Carlsbad, CA, USA). Mouse retinal endothelial 
cells (MRECs) of wild type mice and TLR4 knockout 
mice were purchased from PriCells (Wuhan, China) 
and were cultured in endothelial cell complete medium 
(MED0002 + SUP0002, PriCells) according to the man-
ufacturer’s instructions. Only cells between passages 3 
and 8 were used in the study. The glucose was purchased 
from Sigma-Aldrich, St. Louis, MO, USA. The cells were 
treated with 5.5  mmol/l normal glucose or with 15 and 
25 mmol/l glucose for indicated times in sustained condi-
tion. The cells were also pretreated with TLR4 antagonist 
Rhodobacter sphaeroides LPS (LPS-RS) (Invivogen, San 
Diego, CA, USA) or TLR4 siRNA (Santa Cruz Biotech-
nology, California, USA) according to the instruction of 
manufacture followed by 12 h 5.5, 15, or 25 mmol/l glu-
cose treatment. Cell supernatants, lysates and RNA were 
collected for further experiments.
RNA extraction and real‑time quantitative RT‑PCR
HMEC-1 cells or MRECs were cultured in 30-mm tissue 
culture dishes. After treatment with glucose, total RNA 
was extracted using Trizol reagent (Invitrogen, Carls-
bad, CA, USA) and the cDNA was prepared by reverse 
transcription according to the manufacturer’s protocol. 
Real-time PCR was performed on an Applied Biosystems 
StepOne Real-Time PCR System using the comparative 
threshold cycle (CT) quantification method. Each reac-
tion contained 12.5  μl of 2× SYBR green Master Mix, 
300  nM oligonucleotide primers synthesized by Invit-
rogen Biotechnology Co. Ltd, (Shanghai, China), 10  μl 
of 1 in 10 dilution of the cDNA and water, to a total of 
25 μl. The thermal cycling conditions included an initial 
denaturation at 95  °C for 10 min, 40 cycles at 95  °C for 
30  s, 60  °C for 1  min, and 72  °C for 1  min. The mRNA 
expression in each sample was determined after correc-
tion with the expression of human GAPDH or mouse 
Table 1 Clinical characteristics for  individual proliferative 
retinal membranes and human retina
n/a indicates that there are no duration data for the control subjects
Age 
(years)
Sex Diagnosis Duration of 
diabetes (years)
Patient no.
 1 67 M PDR epiretinal 
membrane
10
 2 48 F PDR epiretinal 
membrane
16
 3 69 M PDR epiretinal 
membrane
8
 4 63 M PDR epiretinal 
membrane
20




 1 52 M Normal n/a
 2 58 F Normal n/a
 3 51 M Normal n/a
 4 60 M Normal n/a
 5 61 M Normal n/a
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GAPDH. Each measurement of a sample was conducted 
in triplicate. The following primers were used: human 
GAPDH (70  bp): forward: CCACATCGCTCAGACAC-
CAT; reverse: CCAGGCGCCCAATACG; human TLR4 
(138  bp): forward: ATGAAATGAGTTGCAGCAGA; 
reverse: AGCCATCGTTGTCTCCCTAA; human 
IL-1β (133  bp): forward: TCCAGGGACAGGATATG-
GAG; reverse: TCTTTCAACACGCAGGACAG; 
human VEGF (120  bp): forward: TCCAGGAGTACC-
CTGATGAG; reverse: ATTCACATTTGTGTGCTGT; 
human bFGF (184  bp): forward: GAGGAGTTGT-
GTCTATCAAAG; reverse: GTTCGTTTCAGT-
GCCACATACC; mouse GAPDH (93  bp): forward: 
TGAGCAAGAGAGGCCCTATC, reverse: AGGCC-
CCTCCTGTTATTATG; mouse IL-1β (105  bp): for-
ward: TCCAGGATGAGGACATGAGCAC, reverse: 
GAACGTCACACACCAGCAGGTTA. All mRNA 
values were normalized against the levels of human or 
mouse GAPDH mRNA. The normalized values of treat-
ment groups are expressed as the fold increase over the 
untreated control cells in y axis.
Western blotting
HMEC-1 cells treated with glucose were collected and 
lysed with lysis buffer containing RIPA and phenyl-
methylsulfonyl fluoride (PMSF). Protein concentration 
was determined by the Bradford–Lowry method and the 
samples were stored at −80  °C until used for immuno-
blot analysis. Protein samples (30 μg) were loaded onto 
SDS-PAGE gels and then were transferred to a PVDF 
membrane (Immobilon-P; Millipore, Bedford, MA, 
USA). After being blocked with 5 % nonfat milk for 1 h, 
the membrane were incubated with the following pri-
mary antibodies at 4 °C overnight: polyclonal rabbit anti-
human TLR4 (1:500; Boster Wuhan, China), polyclonal 
rabbit anti-human MyD88 (1:100; Boster Wuhan, China) 
and monoclonal mouse anti-β-actin (1:100; Boster, 
Wuhan, China). Protein bands were visualized by incuba-
tion with anti-mouse secondary antibody or anti-rabbit 
secondary antibody (1:3000; BOSTER, Wuhan, China) 
and chemiluminescence substrates (ECL Plus; TIAN-
GEN, Beijing, China).
Flow cytometry
HMEC-1 cells were cultured in 24-well plates for at least 
24  h, then were stimulated with 15  mmol/l glucose for 
another 24  h. The cells were then blocked by 5  % BSA 
PBS for 30  min, and were incubated with FITC labeled 
anti-TLR4 antibody (eBioscience Inc., San Diego, CA, 
USA) for 1  h at 4  °C. After the incubation, cells were 
scraped and suspended in 500  μl buffer. The intensity 
of fluorescence was measured using a FACSCalibur and 
CellQuest software (BD PharMingen).
Enzyme‑linked immunosorbent assays (ELISA)
HMEC1 cells with/without siRNA silence or MRECs of 
wild type or TLR4 knockout mice were stimulated with 
glucose. Culture supernatant was harvested, centrifuged 
to remove cellular debris, and then stored at −80 °C until 
use. The concentration of IL-1β in the supernatants was 
measured by human IL-1β ELISA (Boster Corporation, 
Wuhan, China) or mouse IL-1β ELISA (R&D Systems, 
Minneapolis, MN, USA) according to manufacturer’s 
instructions.
Reproducibility and statistical analysis
All experiments were performed at least three times. 
Results were highly reproducible. Representative results 
were shown in figures. Results are expressed as the 
mean ± SE. Data were analyzed by ANOVA with S–N–K 
post hoc analyses. All statistical analyses were performed 
using SPSS20.0 Software. P < 0.05 was considered as sta-
tistically significant.
Results
The expression of TLR4 in premembrane of diabetic 
retinopathy patients
Our previous study showed that TLR4 played a critical 
role in inflammation-induced angiogenesis in a mouse 
model. In this study, we at first examined the expression 
of TLR4 in the premembranes of patients with diabetic 
retinopathy. The premembranes of five diabetic retin-
opathy patients and retinas of five normal human eye 
balls were examined with immunofluorescence staining. 
The expression of TLR4 was detected in the retina from 
normal human eyes (Fig. 1a, Control 1–5) and fibrovas-
cular membranes removed from the eyes of patients with 
PDR (Fig.  1a, PDR 1–5). Positive staining of CD31, an 
endothelial marker, was present in both tissues. Colocali-
zation of TLR4 and CD31 was observed in vessel walls. 
TLR4 expression was significant higher in PDR fibro-
vascular membranes than in normal retinal vasculatures 
(Fig.  1b). These data suggest that TLR4 expression is 
increased in the fibrovasculature and may play a role in 
the dysfunction of vascular endothelial cells in DR.
The expression of TLR4 in retinal endothelial cells 
in STZ‑induced diabetic mice
STZ-induced diabetes in mice is a commonly used model 
to study nonproliferative DR. We examined the expres-
sion of TLR4 in mice 6 and 8  weeks after STZ injec-
tion (Fig.  2a, c). Colocalization of TLR4 and CD31 was 
observed in vessel walls. We found that in the diabetic 
retina, TLR4 level was significantly increased at 6 and 
8  weeks after STZ injection compared to control mice 
(Fig. 2b, d).
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High glucose culture induced the expression of TLR4 
by HMEC‑1 cells
We then used HMEC-1 cells as a model to examine 
microvascular endothelial cell response to increased 
concentration of glucose. HMEC-1 cells were exposed 
to 5.5 (normal), 15 and 25  mmol/l glucose for vari-
able time points. Increased expression of TLR4 mRNA 
was observed after glucose exposure and the high-
est level of TLR4 expression was induced by 25 mmol/l 
glucose (Fig.  3a). The increase in TLR4 expression by 
HMEC-1 cells in response to glucose was time depend-
ent and reached the maximum at 6  h after treatment 
(Fig.  3b). Western blotting (Fig.  3c) showed a markedly 
increase in TLR4 expression at 12 and 24  h after high 
glucose challenge. Analysis of flow cytometry showed 
similar effect when glucose was used at 15 and 25 mmol/l 
(Fig. 3d).
Induction of MyD88 expression in HMEC‑1 cells by high 
glucose
Activation of MyD88 is a key step in the TLR4 pathway 
that culminates in NF-κB activation and inflammatory 
cytokine expression. We examined the effect of high 
glucose on the expression of MyD88 by HMEC-1 cells 
using Western blotting. We observed that high glucose 
increased the expression of MyD88 by HMEC-1 cells at 
15 and 25 mmol/l for 12 h (Fig. 4a). These findings indi-
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Fig. 1 Expression of TLR4 in PDR fibrovascular membrane. Immunofluorescence staining of TLR4 (green) and CD31 (red) was performed in normal 
human retinas, fibrovascular membranes from PDR patients. Results show five fibrovascular membranes from patients with PDR and five normal 
human eye ball controls (a). TLR4 immunofluorescence relative intensity in retinal sections was quantified and displayed (b). *P < 0.05 compared to 
the control group. Scale bar 20 μm
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exposure induces the expression of MyD88, which may 
activate inflammatory cascade.
Increased inflammatory cytokine production by HMEC‑1 
cells in response to high glucose
To investigate the inflammatory response of TLR4, we 
determined the expression of inflammatory cytokine 
IL-1β as well as VEGF and bFGF by HMEC-1 cells under 
high glucose condition. The level of IL-1β mRNA after 
15 and 25  mmol/l glucose treatment was significantly 
increased compared with treatment with 5.5  mmol/l 
glucose (Fig. 4b) (p < 0.05). Kinetic study showed treat-
ment with 15  mmol/l glucose significantly increased 
IL-1β mRNA at 3, 6, 12 and 24  h (Fig.  4c). We then 
measured IL-1β protein in the cultural supernatant of 
glucose-treated HMEC-1 cells. IL-1β level was signifi-
cantly increased at 6, 12, 24 h and persisted under high 
glucose condition (15 mmol/l) (Fig. 4d). Similarly, stimu-
lation of HMEC-1 cells by 15 mmol/l glucose enhanced 
the expression of VEGF and bFGF (Additional file 1: Fig-
ure S1). Therefore, high glucose elevates the secretion of 
inflammatory and proangiogenic cytokines via activation 
of TLR4 pathway.
Inflammatory response activated by high glucose via TLR4 
in HMEC‑1 cells
siRNA was used to confirm the role of TLR4 in high glu-
cose-induced inflammatory response. TLR4 expression 
in HMEC-1 cells was significantly decreased after siRNA 
transfection (Fig. 5a). This resulted in significant decrease 
in IL-1β level at 15  mmol/l glucose treatment (Fig.  5b). 
Scrambled siRNA had no significant effect on IL-1β 
expression by HMEC-1 cells (Fig. 5b). We also tested the 
effects of a TLR4 antagonist, Rhodobacter sphaeroides 
LPS (LPS-RS), on high glucose-induced inflammatory 
response in HMEC-1 cells. LPS-RS reduced the produc-
tion of IL-1β by HMEC-1 cells at 15 mmol/l glucose treat-
ment (Fig. 5c). These findings confirmed that the effect of 
high glucose on the production of IL-1β by HMEC-1 cells 
was TLR4-dependent.
Reduction of high glucose‑induced cytokine production 
by MRECs from TLR4 deficient mice
Next, we determined the expression of IL-1β under high 
glucose condition by MRECs from TLR4 deficient mice. 
Real-time PCR showed that the expression of IL-1β 
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Fig. 2 Expression of TLR4 in retinal vessel of diabetic mice. Immunofluorescence staining of TLR4 (green) and CD31 (red) was performed in normal 
and diabetic mouse retinas. a, c Representative results from three independent experiments with four diabetic and control animals in 6 week-group 
(a) or 8 week-group (c) after STZ injection are shown. b, d TLR4 immunofluorescence relative intensity in retinal sections of 6 week-group (b) or 
8 week-group (d) of diabetic mice was quantified. *P < 0.05 compared to the control group. Scale bar 50 μm
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Fig. 3 Expression of TLR4 in HMEC-1 cells subjected to high glucose. a HMEC-1 cells were stimulated with glucose at the doses of 15 and 
25 mmol/l for 6 h. The mRNA for TLR4 was detected by quantitative RT-PCR and normalized to GAPDH. Asterisk indicates P < 0.05 compared to 
5.5 mmol/l glucose. b The cells were stimulated with 15 mmol/l glucose for 0, 1, 3, 6, 12 and 24 h. The mRNA of TLR4 was detected by quantitative 
RT-PCR and normalized to GAPDH and expressed as the mean ± SE. *P < 0.05 compared to the 0 h group. c HMEC-1 cells were treated with 5.5, 15 
and 25 mmol/l glucose for 6, 12 and 24 h and western blot was performed. β-actin was used as a control. d TLR4 expression on HMEC-1 cells chal-
lenged with 15 mmol/l glucose for 24 h assessed by flow cytometry
d * 


















































Fig. 4 Activation of MyD88 and cytokine expression in HMEC-1 cells under high glucose condition. a Western blotting was performed for MyD88 
expression in the HMEC-1 cells after exposure to 15 and 25 mmol/l glucose for 12 h. β-actin was used as a control. b Cells were treated with 15 and 
25 mmol/l glucose for 6 h. The mRNA for IL-1β was detected by quantitative RT-PCR and normalized to GAPDH. Asterisk indicates P < 0.05 compared 
to 5.5 mmol/l glucose. c The cells were stimulated with 15 mmol/l glucose for 0, 1, 3, 6, 12 and 24 h. The mRNA of IL-1β was detected by quantitative 
RT-PCR and normalized to GAPDH to the 0 h group and expressed as the mean ± SE. *P < 0.05 compared to the 0 h group. d IL-1β protein in the 
supernatants of HMEC-1 cells after high-glucose treatment for indicated time points measured using ELISA. Asterisk indicates P < 0.05 compared to 
5.5 mmol/l glucose
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increased. However, the expression of IL-1β in MRECs 
from TLR4 deficient mice was significantly reduced 
(Fig. 6a) (p < 0.05). Similarly, the production of IL-1β pro-
tein by MRECs from TLR4−/− mice was also significantly 
reduced in comparison with WT mouse cells (Fig.  6b) 
(p < 0.05). These data confirm that TLR4 plays a critical 
role in high glucose-induced inflammatory responses in 
endothelial cells.
Discussion
Diabetic retinopathy is a common vascular complica-
tion and appears to involve inflammatory responses 
[30]. Hyperglycemia induces inflammation, affects the 
production of extracellular matrix and procoagulant 
proteins, causes apoptosis and inhibits the proliferation 
of endothelial cells. These events resulted in endothelial 
dysfunction in diabetic retinopathy [31].
Abnormalities in glucose concentration have been 
reported to elevate and activate TLR4 to promote the 
secretion of inflammatory cytokines in mouse mesangial 
cells and contribute to diabetic nephropathy [14, 23]. The 
expression and function of TLR4 are elevated in mono-
cytes of diabetic patients [17, 32]. Genetic deficiency of 
TLR4 is associated with significant reduction of aortic 
plaque and lower triglyceride accumulation in the heart 
in early stages of diabetes [13, 33]. In addition, TLR4 gene 
polymorphism was found to be associated with diabetic 
retinopathy [15]. Thus, our findings of increased TLR4 in 
endothelial cells after high glucose exposure provide the 
evidence for the role of TLR4 in diabetic retinopathy.
Hyperglycemia, particularly the fluctuation of glucose 
levels, causes a significant oxidative stress, decreas-
ing the expression of endothelial nitric oxide syn-


































Fig. 5 Inhibition of TLR4 reduces high glucose-induced production 
of IL-1β by HMEC-1 cells. a Western blot analysis of TLR4 expression 
by HMEC-1 cells under high glucose condition after siRNA treat-
ment. NG normal glucose, HG high glucose, Sc scrambled control 
siRNA, si2 TLR4 siRNA 0.2 pmol/l, si4 TLR4 siRNA 0.4 pmol/l, si8 TLR4 
siRNA 0.8 pmol/l. b IL-1β concentration in supernatants of HMEC-1 
cells after high-glucose treatment in the presence of TLR4 siRNA 
(0.8 pmol/l) was measured using ELISA. Asterisk indicates P < 0.05 
compared to 5.5 mmol/l glucose. c IL-1β level in supernatants of 
HMEC-1 cells in the presence of TLR4 antagonist LPS-RS (1 μg/ml) 
after high-glucose treatment was measured using ELISA. Asterisk 
































Fig. 6 The expression of IL-1β by MRECs from TLR4 deficient mice 
under high glucose condition. MRECSs of wild type (WT) mice and 
TLR4 knockout (TLR4 KO) mice were cultured with 5.5 and 15 mmol/l 
glucose for 6 h (a) and 24 h (b). a The mRNA level of IL-1β was 
determined by real time PCR. Asterisk indicates P < 0.05 compared to 
WT mice. b IL-1β protein concentration in the supernatants of MRECs 
after high-glucose treatment for 24 h was measured using ELISA. 
Asterisk indicates P < 0.05 compared to WT mice
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hyperglycemia induces an increased production of col-
lagen. Furthermore, fluctuations of glycemia increase 
endothelial cell apoptosis, endothelial expression of 
adhesion molecules, and vascular smooth muscle cell 
proliferation [35]. Thus, glucose fluctuations appear to be 
more deleterious to vascular cell integrity than constant 
high glucose concentrations.
Oxidative stress plays a critical role in mediating the 
upregulation of TLR4 under hyperglycemic conditions. 
It is reported that hyperglycemia induces TLR4 expres-
sion in hyperglycemic human retinal endothelial cells. It 
also increases both MyD88 and non-MyD88 pathways, 
nuclear factor-κB (NF-κB), biomediators, and monocyte 
adhesion. Antioxidant treatment reduced TLR4 expres-
sion and downstream inflammatory markers [36]. The 
articles by Mudaliar et al. [37] and Lu et al. [38] showed 
that TLR4 play an important role in mediating inflam-
matory pathways in endothelial cells exposed to high 
glucose. Therefore, strategies to block TLR4 signaling 
pathways pose a promising avenue to alleviate diabetic-
induced vascular complications.
Hyperglycemia-induced TLR4 expression in human 
monocytes is associated with increased NAPDH oxidase 
activity triggered by PKC [17]. High glucose increased 
PKC-δ activity that mediates a wide range of cellular 
function including increased translocation of NF-κB 
[39]. Additionally, PKC-δ stimulates p47Phox, a NADPH 
oxidase cytosolic subunit, which in turn stimulates the 
NAPDH oxidase activity to generate ROS critical for 
TLR4-mediated activation of NF-κB. Furthermore, high 
glucose was found to enhance the apoptosis of endothe-
lial cells by activation of PKC and NAPDH [17].
Conclusion
Our study demonstrated that hyperglycemia enhances 
the expression of TLR4 and activates TLR4 in human 
endothelial cells that may play an important role in 
diabetic retinopathy. Thus, targeting TLR4 signaling 
pathway may be a novel therapeutic approach to vascula-
ture-related disorders.
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